APPH — Apontis Pharma AG Balance Sheet
0.000.00%
Last trade - 00:00
- €58.98m
- €42.82m
- €36.96m
- 25
- 25
- 59
- 26
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | GAS | GAS | GAS | GAS | GAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 7.39 | 8.06 | 29.8 | 36.3 | 26.8 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1.3 | 1.47 | 3.02 | 2.44 | 1.2 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 13.4 | 12.9 | 38 | 42.4 | 35.1 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.068 | 0.041 | 0.019 | 0.045 | 0.03 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 30.6 | 29.7 | 54.1 | 59.9 | 57.5 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 3.63 | 4.31 | 3.68 | 5.96 | 11.3 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 25.9 | 26.2 | 13.4 | 18.3 | 27.2 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Total Equity | 4.64 | 3.46 | 40.7 | 41.6 | 30.3 |
Total Liabilities & Shareholders' Equity | 30.6 | 29.7 | 54.1 | 59.9 | 57.5 |
Total Common Shares Outstanding |